Endovasc buys women's health company
This article was originally published in Clinica
Executive Summary
Endovasc has signed a non-binding letter of intent to acquire Israeli women's health company Intermed 2000. Drug delivery company Endovasc said that its experience with the "legacy of neglect" in the field of heart disease and other conditions affecting women, prompted the acquisition, for an undisclosed amount.